Traction News and Research RSS Feed - Traction News and Research

ASTRO clinical practice statement outlines recommendations to customize treatment for rectal cancer

ASTRO clinical practice statement outlines recommendations to customize treatment for rectal cancer

The American Society for Radiation Oncology recently issued a new clinical practice statement, "Appropriate Customization of Radiation Therapy for Stage II and III Rectal Cancer: An ASTRO Clinical Practice Statement Using the RAND/UCLA Appropriateness Method." [More]
Medical weight-loss programs help people develop healthier lifestyle habits

Medical weight-loss programs help people develop healthier lifestyle habits

Because Valerie Prim grew up in a large Italian family, food has always been an important part of her life. [More]

Experts describe pathway to limit blurring of boundaries between medical intelligence, securitisation of health threats

Society must align the overlapping priorities and often clashing interests of medical intelligence, national security agendas and the global health community, according to global health advocates writing in the Journal of the Royal Society of Medicine. [More]
Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire plc announces that the U.S. Food and Drug Administration has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients. [More]
Osprey Medical announces record sales for medical device

Osprey Medical announces record sales for medical device

Osprey Medical has announced record sales results for the second quarter of CY2016, reflecting strong adoption by physicians and hospitals of Osprey’s technology protecting patients from the harmful effects of X-ray dye. [More]
TPU scientists develop robotic arm prototype controlled by algorithm using myoelectric signals

TPU scientists develop robotic arm prototype controlled by algorithm using myoelectric signals

Scientists from Tomsk Polytechnic University are developing a robotic arm prototype and its control algorithm using myoelectric signals. The mechanical limb will independently recognize the motions of its owner and be able to perform all the same motions like a healthy arm. [More]
Molecular imaging technique could help optimize radiotherapy dose to combat NETs

Molecular imaging technique could help optimize radiotherapy dose to combat NETs

Aggressive neuroendocrine cancer is something of a dark horse--a rare, elusive and persevering force linked to discouraging long-term survival rates. [More]
Inhibiting autophagy can effectively block tumor cell migration, breast cancer metastasis

Inhibiting autophagy can effectively block tumor cell migration, breast cancer metastasis

Researchers from the University of Chicago have shown that inhibiting autophagy, a self-devouring process used by cells to degrade large intra-cellular cargo, effectively blocks tumor cell migration and breast cancer metastasis in tumor models. [More]

MIT researchers test tiny origami robot that unfolds from swallowed capsule in simulated stomach

In experiments involving a simulation of the human esophagus and stomach, researchers at MIT, the University of Sheffield, and the Tokyo Institute of Technology have demonstrated a tiny origami robot that can unfold itself from a swallowed capsule and, steered by external magnetic fields, crawl across the stomach wall to remove a swallowed button battery or patch a wound. [More]
NHS: a health service or an illness service? An interview with Dr Paula Crick

NHS: a health service or an illness service? An interview with Dr Paula Crick

I've been a nurse for almost 32 years and one of the things that has always been difficult for me to comprehend is that all too often we treat people who are sick, having missed opportunities to prevent, screen or intervene. [More]
PAH role proposed for left heart failure biomarker

PAH role proposed for left heart failure biomarker

Levels of galectin-3 are elevated in patients with pulmonary arterial hypertension and correlate with disease severity, research shows. [More]
New study could help explain critical shortcomings in stem cell-driven therapies for heart disease

New study could help explain critical shortcomings in stem cell-driven therapies for heart disease

With every heart attack, billions of cardiomyocytes, the contracting heart muscle cells that make the heart pump time after time over a lifetime, are lost which can lead to heart failure or injury. Stem cell-based replacement strategies could open new and much needed therapeutic avenues. [More]
Framework for improving chemical hazard assessment without animals

Framework for improving chemical hazard assessment without animals

A new paper published in Regulatory Toxicology and Pharmacology, co-authored by the Physicians Committee for Responsible Medicine, calls for ongoing development and regulatory acceptance of adverse outcome pathways (AOPs), a framework for improving chemical hazard assessment by prioritizing modern test methods that reduce animal use. [More]
Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015. [More]
First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR). [More]
AiCure closes $12.25 million in Series A fundraising round

AiCure closes $12.25 million in Series A fundraising round

AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates. [More]
Several therapies for hemophilia A, hemophilia B and hemophilia with inhibitors to be launched between 2015-2025

Several therapies for hemophilia A, hemophilia B and hemophilia with inhibitors to be launched between 2015-2025

Decision Resources Group forecasts that several therapies will launch for hemophilia A, hemophilia B and hemophilia with inhibitors in the United States and Europe during our 2015-2025 study period. [More]
Minority groups in the U.S. less likely than white people to trust doctors

Minority groups in the U.S. less likely than white people to trust doctors

When it comes to trust in their physicians, minority groups in the United States are less likely than white people to believe their doctors care about them, according to research by University of Pennsylvania's Abigail Sewell. [More]
TCS, VUMC partner to drive innovation in healthcare and life sciences fields

TCS, VUMC partner to drive innovation in healthcare and life sciences fields

Tata Consultancy Services, a leading global IT services, consulting and business solutions organization, today announced a new partnership with Vanderbilt University Medical Center to drive innovation in the healthcare and life sciences fields. [More]

Merus reports revenues of $49.0 million for fiscal 2015

Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015. [More]
Advertisement
Advertisement